Loading insider details...
Beta
Latest Form 4 (Oct 8, 2026): Exercise/Conversion of 20,000 HALO shares, $368.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 8, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Exercise/Conversion | 20,000 | $368.2K |
| Sep 12, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Exercise/Conversion | 20,000 | $368.2K |
| Aug 20, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Exercise/Conversion | 20,000 | $368.2K |
| Jul 9, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Exercise/Conversion | 1,923 | $23.2K |
| Jun 4, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Exercise/Conversion | 20,000 | $241.4K |
| May 13, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Exercise/Conversion | 20,000 | $241.4K |
| Apr 7, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Exercise/Conversion | 10,000 | $120.7K |
| Apr 2, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Exercise/Conversion | 20,000 | $241.4K |
| Mar 4, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Exercise/Conversion | 20,000 | $241.4K |
| Feb 24, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Exercise/Conversion | 16,757 | n/a |